NEWSTEM
NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness. NewStem is a spinoff of Yissum, The Technology Transfer Company of The Hebrew University. NewStem's technology can predict patients' resistance to chemotherapy allowing for better, targeted cancer treatments and the potential to reduce resistance to chemotherapy.
NEWSTEM
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2016-09-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.newstem.com
Total Employee:
1+
Status:
Active
Total Funding:
4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Organization Schema Google Maps
Current Employees Featured
Founder
Investors List
Illumina Accelerator
Illumina Accelerator investment in Seed Round - NewStem
Hollywood Media Corp.
Hollywood Media Corp. investment in Seed Round - NewStem
Official Site Inspections
http://www.newstem.com
- Host name: box5754.bluehost.com
- IP address: 162.241.253.12
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "NewStem"
NewStem | Haploid HESC: Half the Genome - Infinite Potential
With its in-depth understanding of human stem cells and its proprietary technology of haploid human embryonic stem cells, NewStem intends to change the paradigm of life sciences and …See details»
About - NewStem
NewStem is a Bio-Platform company developing precision medicine therapeutics based on Synthetic Lethal interactions with cancer-related mutations causing genomic instability, and diagnostics for anti-cancer drug resistance.See details»
NewStem - Crunchbase Company Profile & Funding
NewStem is a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness. NewStem is a spinoff of Yissum, The Technology …See details»
Home | NovelStem
Dec 14, 2022 · NovelStem International Corp. focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to …See details»
NewStem | NovelStem
NewStem possesses pioneering intellectual property, reagents and experience related to the isolation and differentiation of HhPSCs and HPSCs, their genetic manipulation, immunogenicity, tumorigenicity and their unique capacity in …See details»
Newstem Biotechnologies, Inc. - VentureRadar
Develops biopharmaceutical solutions using human Pluripotent Stem Cells (hPSCs) to advance regenerative medicine, disease therapy, and cancer research with proprietary intellectual …See details»
NewStem Company Profile - Office Locations, Competitors ... - Craft
NewStem is a biopharmaceutical company that specializes in human haploid pluripotent stem cells (HHPSCs). The pluripotent stem cell characteristics enable the differentiation into other …See details»
NewStem - Precision Medicine Therapeutics | Startup Nation Finder
Sep 2, 2018 · NewStem has developed a novel technology for predicting resistance to anticancer treatments. The company is creating a diagnostic tool based on pioneering research in the …See details»
NovelStem Announces NewStem, Ltd. Was Selected by Illumina …
Sep 20, 2021 · NewStem has developed a novel stem-cell-based technology platform for the development of therapeutics and diagnostics. Using this technology, NewStem has identified …See details»
NovelStem Announces NewStem Selected by Illumina …
Sep 20, 2021 · Illumina Accelerator provides selected companies with access to seed investment, access to Illumina sequencing systems and reagents, as well as business guidance, genomics expertise, and fully operational lab space. …See details»
Jerusalem-based NewStem Ltd. Selected for the Global Illumina ...
Sep 29, 2021 · NewStem, along with six other genomic companies, was selected by Illumina for its global Illumina Accelerator. NewStem Ltd main investor, NovelStem International Corp. m …See details»
NovelStem Announces NewStem, Ltd. was Selected by Illumina for …
Sep 20, 2021 · NewStem has developed a novel stem-cell-based technology platform for the development of therapeutics and diagnostics. Using this technology, NewStem has identified …See details»
NewStem Files FDA Pre-Submission & EMA IVDD for …
Apr 19, 2022 · NewStem Ltd filed for a pre-submission to the FDA for a De Novo Request and an in vitro cancer diagnostic device (IVDD) to the EMA (the European Medicines Agency) for their …See details»
News | NewStem
NovelStem International Corp., a biotechnology company focused on stem-cell-based diagnostic technology to aid the selection of cancer therapeutic agents being developed by its Israel …See details»
NovelStem Increases NewStem Ownership to 33% as NewStem …
Dec 1, 2020 · NovelStem has completed the final $1M tranche of its NewStem investment, increasing its ownership to 33%, following NewStem’s successful, on-time completion of all …See details»
Technology - NewStem
Our technology has changed the dogma and enables what was formerly impossible: haploid human eggs can now be artificially induced to divide as early haploid embryos, allowing for the …See details»
NovelStem Increases NewStem Ownership to 33% as NewStem …
Dec 1, 2020 · NovelStem has completed the final $1M tranche of its NewStem investment, increasing its ownership to 33%, following NewStem’s successful, on-time completion of all …See details»
NewStem Announces New Collaboration to Validate its Software …
Dec 14, 2022 · Jerusalem, Israel — December 14, 2022 – NewStem Ltd., a bio-platform company, today announced a collaboration with the MSK Innovation Hub to further optimize …See details»
Technology | NovelStem
NewStem Diagnostic is an expansive, sustainable and personalized rapid screening for anti-cancer drug resistance based on the specific characterization of the patient’s cancer …See details»
Therapeutics - NewStem
For the first time, NewStem’s Proprietary Haploid ESCs introduces expansive screenings capabilities. This advances our comprehension of human biology in health and disease as well …See details»